Targeting BCL-2-like Proteins to Kill Cancer Cells
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference147 articles.
1. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics;Kerr;Br. J. Cancer,1972
2. Targeting BCL2 for the treatment of lymphoid malignancies;Anderson;Semin. Hematol.,2014
3. Progress in BCL2 inhibition for patients with chronic lymphocytic leukemia;Tam;Semin. Oncol.,2016
4. Directly targeting the mitochondrial pathway of apoptosis for cancer therapy with BH3 mimetics: recent successes, current challenges and future promise;Sarosiek;FEBS J.,2016
5. Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases;Strasser;EMBO J.,2011
Cited by 110 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Emerging biomarkers and potential therapeutics of the BCL-2 protein family: the apoptotic and anti-apoptotic context;Egyptian Journal of Medical Human Genetics;2024-01-27
2. Treatment of Double-Refractory Chronic Lymphocytic Leukemia—An Unmet Clinical Need;International Journal of Molecular Sciences;2024-01-27
3. Delayed Reaction of Radiation on the Central Nervous System and Bone System in C57BL/6J Mice;International Journal of Molecular Sciences;2023-12-26
4. A guide to cell death pathways;Nature Reviews Molecular Cell Biology;2023-12-18
5. Statin-induced Mitochondrial Priming Sensitizes Multiple Myeloma Cells to BCL2 and MCL-1 Inhibitors;Cancer Research Communications;2023-12-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3